This news release contains updated information from the researcher that was not in the abstract. (NewMediaWire) - November 18, 2024 - CHICAGO-- A clinical trial testing muvalaplin, a novel oral ...
SHANGHAI and SANTA BARBARA, Calif., Dec. 17, 2025 /PRNewswire/ -- Rona Therapeutics, a global leader in next-generation RNAi medicines, today announced the submission of RN5681 to the Australian Human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback